PI
CVS icon

Parkside Investments’s CVS Health CVS Stock Holding History

Parkside Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.61M Buy
73,517
+783
+1% +$69.9K 0.84% 35
2026
Q1 		$5.22M Sell
72,734
-10,938
-13% -$843K 0.63% 45
2025
Q4 		$6.64M Buy
83,672
+34
+0% +$2.68K 0.84% 40
2025
Q3 		$6.31M Buy
83,638
+5,849
+8% +$401K 0.79% 41
2025
Q2 		$5.37M Buy
77,789
+1,705
+2% +$112K 0.73% 42
2025
Q1 		$5.15M Buy
76,084
+20,407
+37% +$1.22M 0.76% 44
2024
Q4 		$2.5M Sell
55,677
-56,824
-51% -$3.19M 0.37% 51
2024
Q3 		$7.01M Sell
112,501
-15,091
-12% -$880K 1.06% 39
2024
Q2 		$7.54M Sell
127,592
-6,313
-5% -$395K 1.19% 36
2024
Q1 		$10.7M Buy
133,905
+2,393
+2% +$183K 1.69% 16
2023
Q4 		$10.4M Buy
131,512
+517
+0.4% +$36.8K 1.76% 18
2023
Q3 		$9.15M Buy
130,995
+3,520
+3% +$249K 1.68% 23
2023
Q2 		$8.81M Buy
127,475
+15,106
+13% +$1.07M 1.64% 25
2023
Q1 		$8.35M Buy
112,369
+3,438
+3% +$288K 1.57% 28
2022
Q4 		$10.2M Buy
108,931
+1,257
+1% +$121K 2.02% 12
2022
Q3 		$10.3M Sell
107,674
-7,705
-7% -$763K 2.2% 12
2022
Q2 		$10.7M Sell
115,379
-12,445
-10% -$1.21M 2.25% 10
2022
Q1 		$12.9M Buy
127,824
+17,630
+16% +$1.85M 2.53% 9
2021
Q4 		$9.98M Buy
110,194
+3,880
+4% +$359K 1.92% 13
2021
Q3 		$9.02M Buy
106,314
+6,081
+6% +$509K 1.89% 12
2021
Q2 		$8.36M Sell
100,233
-904
-0.9% -$74K 1.61% 15
2021
Q1 		$7.61M Buy
101,137
+7,255
+8% +$528K 1.58% 17
2020
Q4 		$6.41M Buy
93,882
+6,674
+8% +$434K 1.42% 21
2020
Q3 		$5.09M Buy
87,208
+7,225
+9% +$450K 1.34% 26
2020
Q2 		$5.2M Buy
79,983
+14,075
+21% +$886K 1.37% 18
2020
Q1 		$3.91M Buy
65,908
+13,813
+27% +$922K 1.29% 29
2019
Q4 		$3.87M Sell
52,095
-10,863
-17% -$763K 0.94% 43
2019
Q3 		$3.97M Buy
62,958
+50,958
+425% +$3.02M 1.06% 37
2019
Q2 		$654K Buy
+12,000
New +$646K 0.17% 83

Other funds holding CVS

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Parkside Investments's CVS Position: Q2 2026 in Review

Parkside Investments increased its CVS Health (CVS) stake by 1.1% in Q2 2026, buying an estimated $69.9K and bringing the position to 73,517 shares worth $7.61M. The position accounts for 0.84% of the portfolio, ranked #35.

Parkside Investments first reported a position in CVS in Q2 2019 and has held it in 29 quarters since. The position peaked at $12.9M in Q1 2022. 722 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Parkside Investments held 73,517 shares of CVS Health worth $7.61M as of Q2 2026.
  • Parkside Investments bought 783 CVS Health shares in Q2 2026, an estimated $69.9K.
  • CVS Health made up 0.84% of Parkside Investments's portfolio in Q2 2026, its #35 holding.
  • Parkside Investments first reported a position in CVS Health in Q2 2019 and has held it in 29 quarters since.
  • Parkside Investments's CVS Health position peaked at $12.9M in Q1 2022.
  • 722 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Parkside Investments's 13F filing for Q2 2026, filed 13 Jul 2026.